Pfizer Inc. stock has analyst call on November 3, 2026, little changed pre-market
Published on 10/23/2026 at 08:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCompany schedule and business profile
- The company has scheduled an analyst conference call for November 3, 2026.
- Pfizer develops medicines and vaccines for patients across several therapeutic areas.
- Pfizer Inc. stock trades pre-market at EUR 27.11 at 8:06 a.m. CEST at Lang & Schwarz on October 23, 2026, 0.22 percent above the Xetra close of October 22, 2026.
Pfizer Inc.'s November 3, 2026 analyst conference call is the next company date listed on Pfizer's website. At 8:06 a.m. CEST on October 23, 2026, Pfizer Inc. stock trades pre-market at EUR 27.11 at Lang & Schwarz, 0.22 percent above the Xetra close of October 22, 2026 (EUR 27.05). The company date is identified in a Pfizer release dated September 22, 2026.
Analyst conference call
Pfizer's website lists a webcast of the November 3 conference call with analysts among its press releases. The event falls within the next ten Xetra trading days and is the next dated item identified for the company. The listing is provided by Pfizer.
Early indication
The indication is EUR plus 0.06 versus the reference, leaving the stock slightly above the Xetra closing level. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Pfizer stock.
Business and agenda
Pfizer develops and produces medicines and vaccines for use across areas including internal medicine, inflammation and immunology, vaccines and oncology. The November 3 analyst conference call is the next scheduled company date in the period ahead. Market context: Market report S&P 500.
